241 related articles for article (PubMed ID: 12468427)
1. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).
Guan Y; Gerhard B; Hogge DE
Blood; 2003 Apr; 101(8):3142-9. PubMed ID: 12468427
[TBL] [Abstract][Full Text] [Related]
2. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines.
Ailles LE; Gerhard B; Hogge DE
Blood; 1997 Oct; 90(7):2555-64. PubMed ID: 9326221
[TBL] [Abstract][Full Text] [Related]
4. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
5. Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML).
Guan Y; Hogge DE
Leukemia; 2000 Dec; 14(12):2135-41. PubMed ID: 11187903
[TBL] [Abstract][Full Text] [Related]
6. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
Ailles LE; Humphries RK; Thomas TE; Hogge DE
Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
[TBL] [Abstract][Full Text] [Related]
7. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).
Glimm H; Oh IH; Eaves CJ
Blood; 2000 Dec; 96(13):4185-93. PubMed ID: 11110690
[TBL] [Abstract][Full Text] [Related]
8. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
Ailles LE; Gerhard B; Kawagoe H; Hogge DE
Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
[TBL] [Abstract][Full Text] [Related]
9. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
Feuring-Buske M; Frankel A; Gerhard B; Hogge D
Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
[TBL] [Abstract][Full Text] [Related]
10. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
11. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
12. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
13. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
Blair A; Sutherland HJ
Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
[TBL] [Abstract][Full Text] [Related]
14. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
15. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D; Dick JE
Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
[TBL] [Abstract][Full Text] [Related]
16. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.
Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M
J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.
Holyoake T; Jiang X; Eaves C; Eaves A
Blood; 1999 Sep; 94(6):2056-64. PubMed ID: 10477735
[TBL] [Abstract][Full Text] [Related]
18. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice.
Sarry JE; Murphy K; Perry R; Sanchez PV; Secreto A; Keefer C; Swider CR; Strzelecki AC; Cavelier C; Récher C; Mansat-De Mas V; Delabesse E; Danet-Desnoyers G; Carroll M
J Clin Invest; 2011 Jan; 121(1):384-95. PubMed ID: 21157036
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
20. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
